Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma
NCT ID: NCT06111560
Last Updated: 2023-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
160 participants
OBSERVATIONAL
2012-02-01
2022-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
(Inclusion criteria: pathology of the surgical specimen confirmed the diagnosis of pRCC,b: age 18 years or older, c: localized RCC underwent radical nephrectomy or partial nephrectomy in our center.
Exclusion criteria:a: lack of original CT images, b: patients with malignant tumors of other systems, c: patients who lost follow-up.)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens
NCT00718367
Clinicopathological Features of Renal Cell Carcinoma in Young Patients
NCT06730997
Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma
NCT06773377
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
NCT07118813
Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
NCT05214885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with tumor progression or recurrence
Patients enrolled in our retrospective study with tumor progression or recurrence
We do not have any interventions. This study is based on obseravation.
observational retrospective study without any interventions
Patients without tumor progression or recurrence
Patients enrolled in our retrospective study without tumor progression or recurrence
We do not have any interventions. This study is based on obseravation.
observational retrospective study without any interventions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
We do not have any interventions. This study is based on obseravation.
observational retrospective study without any interventions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zheng fufu
Professor,Phd,Md
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wenhui Su, Bachelor
Role: PRINCIPAL_INVESTIGATOR
First affiliated hospital, Sun Yat-sen univeristy
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIT-2023-282
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.